Stay updated on Gilteritinib Combo for Newly Diagnosed AML Clinical Trial
Sign up to get notified when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.

Latest updates to the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.4.2 was added, the previous v3.4.1 revision label and a government-funding notice banner were removed; these are minor site maintenance/versioning updates that do not alter study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check16 days agoChange DetectedNew site notice about government funding lapse and open status is displayed at the top of the page, and the history now shows Revision: v3.4.1 replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check23 days agoChange DetectedNew UI notes explain the glossary display and color coding for additions and deletions in the record history, plus a glossary toggle. The latest revision (v3.4.0) adds No FEAR Act Data, while the prior revision referenced No FEAR Act data.SummaryDifference0.9%

- Check37 days agoChange DetectedA new revision entry (v3.3.4) has been added to the Record History; to avoid alerts for minor changes, set an alert condition.SummaryDifference0.1%

- Check59 days agoChange DetectedA new 'Study Status' entry was added to the record history (revision v3.3.3) on 2025-12-16. The 'HHS Vulnerability Disclosure' link was removed (revision v3.3.2) on 2025-12-01.SummaryDifference0.4%

- Check80 days agoChange DetectedThe Record History page now lists a 'Study Status' change and shows an updated latest entry dated 2025-12-01 (version 40).SummaryDifference0.3%

Stay in the know with updates to Gilteritinib Combo for Newly Diagnosed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.